Noze

Noze (formerly Stratuscent) is a Canadian AI startup that has developed a pioneering digital odor perception platform capable of detecting, identifying, and interpreting odors with unparalleled accuracy. Built on NASA-patented technology previously deployed to the International Space Station, Noze's platform utilizes a specialized sensor array that collects data and sends it to a sophisticated AI engine for analysis. This innovative solution enables non-invasive screening and diagnostics of medical conditions through breath and body odor analysis.

During the Covid-19 pandemic in 2020-2021, Noze's technology was among the first to track airborne markers released by individuals infected with the coronavirus and influenza viruses. This breakthrough paved the way for addressing other healthcare challenges by leveraging digital olfaction. Recently, in March 2023, Noze received a USD 1 million grant from the Bill & Melinda Gates Foundation to develop a portable, mass-scale breathalyzer to detect infectious diseases like malaria and tuberculosis through breath biomarkers (VOCs). The diagnostic breathalyzer is targeted for completion by the end of 2023, followed by a clinical validation phase.

Noze's proprietary odor library currently contains over 100 well-curated odor scentprints, powered by nearly 100 million data points. The platform employs novel AI techniques such as meta-learning, few-shot learning, and manifold learning to interpret these scentprints accurately while rejecting background noise. Noze is actively collaborating with partners on health-related projects and clinical trials utilizing its digital odor perception platform.